Benzodiazepine-induced reduction in activity mirrors decrements in cognitive and psychomotor performance

Human Psychopharmacology

Volumn 23, Issue 7, 2008, Pages 605-613

  Dawson, Jean ^a   Boyle, Julia ^a   Stanley, Neil ^a   Johnsen, Sigurd ^a   Hindmarch, Ian ^a   Skene, Debra J ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Actigraphy; Benzodiazepine; Cognitive performance; Psychomotor performance

Indexed keywords

LORAZEPAM; PLACEBO;

ACTIMETRY; ADULT; ARTICLE; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL PERFORMANCE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SLEEP PATTERN; SLEEP TIME;

ADULT; ANTI-ANXIETY AGENTS; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LORAZEPAM; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; SLEEP; TIME FACTORS; YOUNG ADULT;

EID: 57149133295     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.961     Document Type: Article

References (48)

1. Acebo C, Sadeh A, Seifer R, Tzischinsky O, Hafer A, Carskadon MA. 2005. Sleep/wake patterns derived from activity monitoring and maternal report for healthy 1- to 5-year-old children. Sleep 28: 1568-1577.
2. Acebo C, LeBourgeois MK. 2006. Actigraphy. Respir Care Clin N Am 12: 23-30.
3. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. 2003. The role of actigraphy in the study of sleep and circadian rhythms. Sleep 26: 342-392.
4. Borbely AA, Loepfe M, Mattmann P, Tobler I. 1983. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Arzneimittelforschung 33: 1500-1502.
5. Borbely AA. 1984. Ambulatory motor activity monitoring to study the timecourse of hypnotic action. Br J Clin Pharmacol 18: 83S-86S.
6. Borbely AA, Youmbi-Balderer G, Jaggi-Schwarz K. 1988. Zolpidem (10 mg and 20 mg): hypnotic action and residual effects after a single bedtime dose. In Imidazopyridines in Sleep Disorders, Sauvenet JP, Langer SZ, Morselli PL (eds) Raven Press: New York; 205-210.
7. Fairweather DB, Ashford J, Hindmarch I. 1996. Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers. Pharmacol Biochem Behav 53: 256-259.
8. Grozinger M, Kogel P, Roschke J. 1998. Effects of lorazepam on the automatic online evaluation of sleep EEG data in healthy volunteers. Pharmacopsychiatry 31: 55-59.
9. Gudgeon AC, Hindmarch I. 1983. Midazolam: effects on psychomotor performance and subjective aspects of sleep and sedation in normal volunteers. Br J Clin Pharmacol 16: 121-126.
10. Hauri PJ, Wisbey J. 1992. Wrist actigraphy in insomnia. Sleep 15: 293-301.
11. Hindmarch I. 1980. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10: 189-209.
12. Hindmarch I, Subhan Z, Stoker MJ. 1983. The effects of zimeldine and amytriptyline on car driving and psychomotor performance. Acta Psychiatr Scand 68: 141-146.
13. Hindmarch I. 1987. Three antidepressants (amytriptyline, dothiepin, fluoxitine), with and without alcohol, compared to placebo on tests of psychomotor ability related to car driving. Hum Psychopharmacol 2: 177-183.
14. Hindmarch I, Tiplady B. 1994. A comparison of the psychometric effects of remoxipride with those of haloperidol, thioridazine and lorazepam in healthy volunteers. Hum Psychopharmacol 9: 43-49.
15. Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. 1999. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol 48: 200-206.
16. Hindmarch I, Rigney U, Stanley N, Quinlan P, Rycroft J, Lane J. 2000. A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology (Berl) 149: 203-216.
17. Hindmarch I, Patat A, Stanley N, Paty I, Rigney U. 2001. Residual effects of zaleplon and zolpidem following middle of the night administration .ve hours to one hour before awakening. Hum Psychopharmacol 16: 159-167.
18. Hindmarch I, Trick L, Ridout F. 2005. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor pro.le of pregabalin in healthy volunteers. Psychopharmacology (Berl) 183: 133-143.
19. Kawahara R, Nishimura S, Inagaki Y, Taenaka N, Kawahara H. 2002. Actigraphic assessment of the preoperative hypnotic effects of brotizolam and zopiclone. Acta Anaesthesiol Belg 53: 27-31.
20. Kerr JS, Powell J, Hindmarch I. 1996. The effects of reboxetine and amitriptyline, with and without alcohol on cognitive function and psychomotor performance. Br J Clin Pharmacol 42: 239-241.
21. Kiang M, Daskalakis ZJ, Christensen BK, Remington G, Kapur S. 2003. Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects. J Psychiatry Neurosci 28: 293-299.
22. King MA, Jaffre MO, Morrish E, Shneerson JM, Smith IE. 2005. The validation of a new actigraphy system for the measurement of periodic leg movements in sleep. Sleep Med 6: 507-513.
23. Klosch G, Gruber G, Anderer P, Saletu B. 2001. Activity monitoring in sleep research, medicine and psychopharmacology. Wien Klin Wochenschr 113: 288-295.
24. Kyriakopoulos AA, Greenblatt DJ, Shader RI. 1978. Clinical pharmacokinetics of lorazepam: a review. J Clin Psychiatry 39: 16-23.
25. Lichstein KL, Stone KC, Donaldson J, et al. 2006. Actigraphy validation with insomnia. Sleep 29: 232-239.
26. Littner M, Kushida CA, Anderson WM, et al. 2003. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep 26: 337-341.
27. Lockley SW, Skene DJ, Arendt J. 1999. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 8: 175-183.
28. Mattmann P, Loepfe M, Scheitlin T, et al. 1982. Day-time residual effects and motor activity after three benzodiazepine hypnotics. Arzneimittelforschung 32: 461-465.
29. Oakley NR. 1997. Validation with polysomnography of the Sleepwatch sleep/ wake scoring algorithm used by the Actiwatch activity monitoring system. Technical Report to Mini-Mitter Co., Inc.
30. Parkin C, Fairweather DB, Shamsi Z, Stanley N, Hindmarch I. 1998. The effects of cigarette smoking on overnight performance. Psychopharmacology (Berl) 136: 172-178.
31. Parkin C, Kerr JS, Hindmarch I. 1999. The effects of practice on choice reaction time and critical flicker fusion threshold. Hum Psychopharmacol 12: 65-70.
32. Patat A, Klein MJ, Hucher M. 1987. Effects of single oral doses of clobazam, diazepam and lorazepam on performance tasks and memory. Eur J Clin Pharmacol 32: 461-466.
33. Papini O, Bertucci C, da Cunha SP, dos Santos N, Lanchote V. 2006. Quantitative assay of lorazepam and its metabolite glucoronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples. J Pharm Biomed Anal 40: 389-396.
34. Raoux N, Benoit O, Dantchev N, et al. 1994. Circadian pattern of motor activity in major depressed patients undergoing antidepressant therapy: relationship between actigraphic measures and clinical course. Psychiatry Res 52: 85-98.
35. Roehrs T, Turner L, Roth T. 2000. Effects of sleep loss on waking actigraphy. Sleep 15: 793-797.
36. Royant-Parola S, Borbely AA, Tobler I, Benoit O, Widlocher D. 1986. Monitoring of long-term motor activity in depressed patients. Br J Psychiatry 149: 288-293.
37. Saletu B, Frey R, Grunberger J, Krupka M, Anderer P, Musch B. 1990. Sleep laboratory studies on single dose effects of suriclone. Br J Clin Pharmacol 30: 703-710.
38. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Wolf SR. 1991. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep 14: 439-447.
39. Sadeh A, Hauri PJ, Kripke DF, Lavie P. 1995. The role of actigraphy in the evaluation of sleep disorders. Sleep 18: 288-302.
40. Shamsi Z, Kimber S, Hindmarch I. 2001. An investigation into the effects of cetirizine on cognitive function and psychomotor performance in healthy volunteers. Eur J Clin Pharmacol 56: 865-871.
41. Sherwood N, Kerr JS. 1993. The reliability, validity and pharmacosensitivity of four psychomotor tests. In Human Psychopharmacology Measures and Methods, Hindmarch I, Stonier PD (eds). John Wiley & Sons: Chichester; 4: 1-14.
42. Soo-ampon S, Wongwitdecha N, Plasen S, Hindmarch I, Boyle J. 2004. Effects of word frequency on recall memory following lorazepam, alcohol, and lorazepam alcohol interaction in healthy volunteers. Psychopharmacology (Berl) 176: 420-425.
43. Stanley N, Hindmarch I. 1997. Actigraphy can measure antidepressant-induced daytime sedation in healthy volunteers. Hum Psychopharmacol 12: 437-443.
44. Stanley N. 1997. Actigraphy in psychopharmacology. In Human Psychopharmacology Measures and Methods, Hindmarch I, Stonier PD (eds). John Wiley & Sons: Chichester; 6: 67-93.
45. Stanley N, Fairweather DB, Hindmarch I. 1999. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients. Neuropsychobiology 39: 44-48.
46. Stanley N. 2003. Actigraphy in human psychopharmacology: A review. Hum Psychopharmacol 18: 39-49.
47. Takahashi T, Okajima Y, Otsubo T, et al. 2003. Comparison of hangover effects among triazolam, flunitrazepam and quazepam in healthy subjects: a preliminary report. Psychiatry Clin Neurosci 57: 303-309.
48. van Laar M, Volkerts E, Verbaten M. 2001. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers. Psychopharmacology (Berl) 154: 189-197.